Xeno Transplants Corporation
XENO
$0.0001
$0.000.00%
| 03/31/2008 | 12/31/2007 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -35.45% | 20.81% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -35.45% | 20.81% | |||
| Operating Income | 35.45% | -20.81% | |||
| Income Before Tax | 35.45% | -20.81% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 35.45% | -20.81% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 35.45% | -20.81% | |||
| EBIT | 35.45% | -20.81% | |||
| EBITDA | 35.53% | -20.74% | |||
| EPS Basic | 35.71% | -20.00% | |||
| Normalized Basic EPS | 34.62% | -18.18% | |||
| EPS Diluted | 35.71% | -20.00% | |||
| Normalized Diluted EPS | 34.62% | -18.18% | |||
| Average Basic Shares Outstanding | 0.00% | 0.10% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.10% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
